Quarterly and annual results disclosed under 8-K Item 2.02.
Madison Square Garden Entertainment Corp. reported fiscal third quarter ended March 31, 2024 results: revenue $228.3 million. Guidance raised.
“For the fiscal 2024 third quarter, the Company reported revenues of $228.3 million, an increase of $27.1 million, or 13%, as compared to the prior year quarter.”
NewAmsterdam Pharma Co N.V. reported financial results for quarter ended March 31, 2024.
“On May 9, 2024, NewAmsterdam Pharma Company N.V. (the “Company”) issued a press release announcing corporate updates and its financial results for the quarter ended March 31, 2024.”
Mineralys Therapeutics, Inc. reported the quarter ended March 31, 2024 results: net income $31.5 million.
“Net loss was $31.5 million for the quarter ended March 31, 2024, compared to $12.6 million for the quarter ended March 31, 2023.”
Granite Ridge Resources, Inc. reported first quarter of 2024 results: net income $16.2 million, EPS $0.12 per diluted share. Guidance reaffirmed.
“Granite Ridge Resources, Inc. (“Granite Ridge” or the “Company”) (NYSE: GRNT) today reported financial and operating results for the first quarter of 2024.”
Syra Health Corp reported first quarter ended March 31, 2024 results: revenue $1.7 million, net income $(1.4 million). Guidance reaffirmed.
“innovative services and technology solutions, announced today its financial results for the first quarter ended March 31, 2024. Q1 2024 Financial Highlights ● Revenue of $1.7 million in 1Q24 compared to $1.2 million in 1Q23. ● Business units excluding Healthcare Workforce grew 333% and comprised 19% of total revenues in 1Q24, versus only 7% in 1Q23. ●”
Jushi Holdings Inc. reported first quarter ended March 31, 2024 results: revenue $65.5 million, net income Net loss of $18.4 million.
“U.S. dollars unless otherwise indicated and is prepared under U.S. Generally Accepted Accounting Principles (“GAAP”). First Quarter 2024 Financial Highlights 1 Total revenue of $65.5 million Gross profit and gross profit margin of $32.3 million and 49.4%, respectively Net loss of $18.4 million Adjusted EBITDA 1 of $13.3 million, an improvement of $5.7 million”
Lexeo Therapeutics, Inc. reported first quarter 2024 results: net income $21.7 million or $0.77 per share (basic and diluted), EPS $0.77 per share (basic and diluted).
“Net loss was $21.7 million or $0.77 per share (basic and diluted) for the three months ended March 31, 2024”
Amprius Technologies, Inc. reported financial results for first fiscal quarter ended March 31, 2024.
“On May 9, 2024, Amprius Technologies, Inc. (the “Company”) announced its business and financial results for its first fiscal quarter ended March 31, 2024.”
Getty Images Holdings, Inc. reported first quarter ended March 31, 2024 results: revenue $222.3 million, net income $13.6 million. Guidance reaffirmed.
“We are confident in our ability to return to topline growth in 2024 as our headwinds turn to tailwinds.” First Quarter 2024 Financial Summary: • Revenue for the period was $222.3 million , a decrease of 5.7% year-over-year on both a reported and currency neutral basis. • Creative revenue was $138.9 million , a decrease of 5.2% year-over-year on both a reported”
Savers Value Village, Inc. reported thirteen weeks ended March 30, 2024 results: revenue $354.2 million, net income $0.00 per diluted share, EPS $0.00 per diluted share.
“the thirteen weeks ended March 30, 2024 (the “first quarter”). Highlights for the First Quarter, Compared to the thirteen weeks ended April 1, 2023 • Net sales increased 2.5% to $354.2 million. • Comparable store sales increased 0.3%, with the United States (“U.S.”) up 2.3% and Canada down 2.6%. • Sales yield 2 increased 1.4% to $1.41 per pound. • The Company ended the”
Structure Therapeutics Inc. reported first quarter ended March 31, 2024 results: net income Net loss for the first quarter of 2024 totaled $26.0 million.
“Structure Therapeutics Inc. (the "Company") issued a press release providing a corporate update and announcing its financial results for the first quarter ended March 31, 2024.”
HilleVax, Inc. reported the quarter ended March 31, 2024 results: net income Net loss for the first quarter 2024 was $46.8 million, compared to $26.9 million for the first quarter 2023.
“HilleVax, Inc. (the "Company") issued a press release announcing its financial results for the quarter ended March 31, 2024.”
ProFrac Holding Corp. reported financial results for first quarter ended March 31, 2024.
“On May 9, 2024, ProFrac Holding Corp., a Delaware corporation (the “ Company ”), issued a press release reporting the financial results of the Company for the quarter ended March 31, 2024.”
Pagaya Technologies Ltd. reported the first quarter ended March 31, 2024 results: revenue $245 million.
“Quarter 2024 Results ● Delivered another record quarter, exceeding guidance on all metrics: ○ Record Network Volume of $2.42 billion ○ Record Total Revenue and Other Income of $245 million ○ Record Adjusted EBITDA of $40 million ● Onboarding a bank partner in our point-of-sale product New York, NY and Tel Aviv, Israel – May 9, 2024 – Pagaya Technologies Ltd.”
Perimeter Solutions, Inc. reported first quarter ended March 31, 2024 results: revenue $59.0 million, net income Net loss during the first quarter was $82.6 million, EPS $0.57 per diluted share.
“phosphorus-based specialty chemicals, today reported financial results for its first quarter ended March 31, 2024. First Quarter 2024 Results • Net sales increased 35% to $59.0 million in the first quarter, as compared to $43.9 million in the prior year quarter. • Fire Safety sales increased 34% to $25.2 million, as compared to $18.7 million in the prior year”
Vacasa, Inc. reported fiscal quarter ended March 31, 2024 results: revenue $209 million, net income $141 million.
“Revenue, which consists primarily of our commission on the rents we generate for homeowners, the fees we collect from guests, and Revenue from home care solutions provided directly to our homeowners, was $209 million in the first quarter of 2024, an 18% decrease compared to the same quarter last year. Despite demonstrating expense discipline across our cost structure, the magnitude of the Revenue decline is impacting our profitability. Net Loss was $141 million for the first quarter of 2024, which includes an $84 million charge associated with the impairment of our long-lived assets.”
Arhaus, Inc. reported first quarter ended March 31, 2024 results: revenue $295 million, net income $15 million. Guidance reaffirmed.
“ended March 31, 2024. A copy of the release is attached as Exhibit 99.1. --- EX-99.1 (EX-99.1) --- ARHAUS ANNOUNCES FIRST QUARTER 2024 FINANCIAL RESULTS Net Revenue of $295 million, Net Income of $15 million, and Adjusted EBITDA of $29 million Reaffirming Full Year 2024 Outlook BOSTON HEIGHTS, Ohio—May 9, 2024—Arhaus, Inc. (NASDAQ: ARHS; “Arhaus” or the”
Cyngn Inc. reported fiscal first quarter ended March 31, 2024 results: revenue $5.5 thousand, net income $(6.0) million, EPS $(0.08).
“our customer acquisition costs and enables us to convert more customers to advanced sales discussions.” Q1 2024 Financial Review: ● First quarter revenue was $5.5 thousand compared to $872.8 thousand in the first quarter of 2023. First quarter 2024 revenue consisted of EAS software subscriptions from DriveMod Stock chaser vehicle deployments”
Enfusion, Inc. reported financial results for the fiscal quarter ended March 31, 2024.
“On May 9, 2024, Enfusion, Inc. announced its financial results for the fiscal quarter ended March 31, 2024. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.”
Embecta Corp. reported three and six month periods ended March 31, 2024 results: revenue $287.2 million, net income $28.9 million, EPS $0.50. Guidance raised.
“half of the year, we are raising and tightening our fiscal 2024 outlook for our key financial metrics." Second Quarter Fiscal Year 2024 Financial Highlights : • Revenues of $287.2 million, up 3.6% on a reported basis; up 4.5% on a constant currency basis ◦ U.S. revenues increased 0.8% on both a reported and constant currency basis ◦ International revenues”
Solo Brands, Inc. reported first quarter ended March 31, 2024 results: revenue $85.3 million, net income $6.5 million, EPS $(0.06) per diluted share. Guidance reaffirmed.
“people and processes in place to position us to generate consistent long-term growth.” Consolidated First Quarter 2024 Highlights Compared to First Quarter 2023 • Net sales of $85.3 million, down $2.9 million or 3.3% • Net loss of $6.5 million, down $7.4 million • Net loss per Class A common stock - basic and diluted of $0.06, down $0.07 • Adjusted net income (1)(2)”
Xeris Biopharma Holdings, Inc. reported first quarter ended March 31, 2024 results: revenue $40,638, net income $19.0 million, or $0.14 per share. Guidance reaffirmed.
“13,085 12,755 330 2.6 Recorlev 10,599 4,477 6,122 136.7 Product revenue, net 40,263 32,265 7,998 24.8 Royalty, contract and other revenue 375 931 (556) (59.7) Total revenue $ 40,638 $ 33,196 $ 7,442 22.4 Commercial Products • Gvoke® : First quarter net revenue was $16.6 million as compared to $15.0 million in the first quarter of 2023 – an increase of”
Brilliant Earth Group, Inc. reported three months ended March 31, 2024 results: revenue $97.3 million, net income $1.1 million, EPS $0.01. Guidance reaffirmed.
“Net sales of $97.3 million, approximately flat year-over-year, in line with the Company's expectations and reflecting significant share gains”
Amplitude, Inc. reported the first quarter ended March 31, 2024 results: revenue $72.6 million, EPS $(0.18) per share.
“--- EX-99.1 Exhibit 99.1 Amplitude Announces First Quarter 2024 Financial Results • Annual recurring revenue was $285 million, up 9% year over year • First quarter revenue of $72.6 million, up 9% year over year • First quarter Cash Flow from Operations of $(0.05) million and Free Cash Flow of $(1.1) million, representing a 7 percentage point increase in Free Cash”
Tyra Biosciences, Inc. reported the quarter ended March 31, 2024 results: net income First quarter 2024 net loss was $18.2 million.
“On May 9, 2024, Tyra Biosciences, Inc. issued a press release announcing its financial results for the quarter ended March 31, 2024.”
Nuvalent, Inc. reported first quarter 2024 results: net income Net loss was $44.5 million for the first quarter of 2024..
“Net loss was $44.5 million for the first quarter of 2024.”
GigaCloud Technology Inc reported first quarter ended March 31, 2024 results: revenue Total revenues of $251.1 million, net income Net income of $27.2 million, EPS Diluted EPS increased 69.2% to $0.66.
“2024, including substantial growth in revenue, gross profit, and net income over the comparable prior year period. First Quarter 2024 Financial Highlights • Total revenues of $251.1 million, increased 96.5% from $127.8 million in the first quarter of 2023. • Gross profit of $66.5 million, increased 124.7% from $29.6 million in the first quarter of 2023. Gross margin”
Krispy Kreme, Inc. reported the quarter ended March 31, 2024 results: revenue $442.7 million, net income $(6.7) million, EPS $(0.05) per diluted share. Guidance reaffirmed.
“(“Krispy Kreme”, “KKI”, or the “Company”) today reported financial results for the quarter ended March 31, 2024. First Quarter Highlights (vs Q1 2023) • Net revenue grew 5.7% to $442.7 million • Organic revenue grew 6.7% to $440.9 million • GAAP net loss of $6.7 million • GAAP net loss attributable to KKI of $8.5 million • Adjusted EBITDA grew 5.9% to $58.2 million •”
Zura Bio Ltd reported first quarter 2024 results: net income $7.7 million.
“Net loss for the first quarter of 2024 was $7.7 million”
NewLake Capital Partners, Inc. reported first quarter ended March 31, 2024 results: revenue $12.6 million, net income $6.9 million.
“NewLake Capital Partners Reports First Quarter 2024 Financial Results First Quarter 2024 Revenue Totaled $12.6 Million, an increase of 10.4% Year-Over-Year First Quarter 2024 Net Income Attributable to Common Stockholders Totaled $6.9 Million”
Senti Biosciences, Inc. reported first quarter of 2024 results: net income Net loss was $12.1 million, or $0.26 per basic and diluted share, EPS $0.26 per basic and diluted share.
“Senti Biosciences, Inc. issued a press release announcing its financial results for the quarter ended March 31, 2024.”
Ventyx Biosciences, Inc. reported financial results for first quarter ended March 31, 2024.
“today announced financial results for the first quarter ended March 31, 2024”
Century Therapeutics, Inc. reported financial results for first quarter ended March 31, 2024.
“Century Therapeutics, Inc. (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology and autoimmune diseases, today reported financial results and business highlights for the first quarter ended March 31, 2024.”
Telesis Bio Inc. reported the quarter ended March 31, 2024 results: revenue $3.4 million, net income $8.6 million, EPS $5.52.
“strategy, is reduced 31% from the first quarter of the prior year. Summary of First Quarter 2024 Financial Results Revenue for the three months ended March 31, 2024 was $3.4 million compared to $6.3 million for the three months ended March 31, 2023. The decrease of $2.9 million was attributable to a decrease in product revenue of $1.7 million, a decrease in”
FIGS, Inc. reported three months ended March 31, 2024 results: net income Net income ... was $1.4 million.
“were $1.4 million (or $0.01 in diluted earnings per share), a decrease of $0.5 million year over year as compared to net income in the same period last year”
OmniAb, Inc. reported the first quarter of 2024 results: revenue $3.8 million, net income $19.0 million net loss, EPS $0.19 per share loss.
“to continued progress by our partners and expansion of our technology as the year progresses.” First Quarter 2024 Financial Results Revenue for the first quarter of 2024 was $3.8 million, compared with $16.9 million for the same period in 2023, with the decrease primarily due to the recognition in the 2023 period of a $10 million milestone related to the first”
OmniAb, Inc. reported the three months ended March 31, 2024 results: revenue $3.8 million, net income $19.0 million net loss, EPS $0.19 per share loss.
“to continued progress by our partners and expansion of our technology as the year progresses.” First Quarter 2024 Financial Results Revenue for the first quarter of 2024 was $3.8 million, compared with $16.9 million for the same period in 2023, with the decrease primarily due to the recognition in the 2023 period of a $10 million milestone related to the first”
LifeStance Health Group, Inc. reported the first quarter ended March 31, 2024 results: revenue $300.4 million, net income ($21.1 million). Guidance raised.
“LifeStance Reports First Quarter 2024 Results SCOTTSDALE, Ariz. – May 9, 2024 – LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation’s largest providers of outpatient mental healthcare, today announced financial results for the first quarter ended March 31, 2024. (All results compared to prior-year comparative period, unless otherwise noted) Q1 2024 Highlights and FY 2024 Outlook • Revenue of $300.4 million increased 19% compared to revenue of $252.6 million • Clinician base increased 15% to 6,866 clinicians, a sequential net increase of 221 in the first quarter • First quarter visit volumes increased 15% to 1.9 million • Net loss of $21.1 million, primarily driven by stock-based compensation, compared to net loss of $34.2 million”
LanzaTech Global, Inc. reported first quarter 2024 results: revenue $10.2 million, net income $(25.5) million. Guidance reaffirmed.
“--- EX-99.1 (EX-99.1) --- a1q24lnzaearningsrelease LanzaTech Announces First Quarter 2024 Financial Results and Reiterates Full Year 2024 Outlook Achieved total revenue of $10.2 million for first quarter 2024 in-line with annual guidance and consistent with outlook of back-end weighted full year 2024 revenue Reiterating full year 2024 outlook including total”
INTEGRAL AD SCIENCE HOLDING CORP. reported Q1 2024 results: revenue $114.5 million, net income -$1.3 million, EPS -$0.01. Guidance raised.
“Total revenue increased 8% to $114.5 million Net loss of $1.3 million at a 1% net loss margin; adjusted EBITDA of $33.1 million at a 29% margin Introduces positive second quarter outlook and raises full-year outlook”
Marpai, Inc. reported the three months ended March 31, 2024 results: revenue $7.4 million, net income $4.3 million, EPS ($0.46).
“Net revenues were approximately $7.4 million for the three months ended March 31, 2024, down $2.3 million, or 24% lower year over year, compared to the three months ended March 31, 2023.”
Wag! Group Co. reported first quarter ended March 31, 2024 results: revenue $23.2 million, net income Net loss was $4.2 million. Guidance reaffirmed.
“Wag! Group Co. (the "Company" or "Wag!"; Nasdaq: PET), which strives to be the number one platform to solve the service, product, and wellness needs of the modern U.S. pet household, today announced financial results for the first quarter ended March 31, 2024. First Quarter 2024 Highlights: • Revenues increased 13% to $23.2 million, compared to $20.6 million in the first quarter of 2023, a quarterly revenue record – comprised of $5.3 million of Services revenue, $15.8 million of Wellness revenue, and $2.1 million of Pet Food & Treats revenue. • Net loss was $4.2 million, compared to $3.8 million in the first quarter of 2023, driven by costs associated with $5 million debt principal pay down.”
Local Bounti Corporation/DE reported the three months ended March 31, 2024 results: revenue $8.4 million, net income $24.1 million. Guidance initiated.
“the second half of this year to achieve our full year guidance, which calls for a doubling of revenue versus 2023." First Quarter 2024 Financial Summary • Sales increased 25% to $8.4 million in the first quarter of 2024, as compared to $6.7 million in the prior year period. The increase was primarily due to increased production and growth in sales from the Company's”
indie Semiconductor, Inc. reported first quarter ended March 31, 2024 results: revenue $52.4 million, net income $49.6 million, EPS $0.19. Guidance reaffirmed.
“Inc. (Nasdaq: INDI), an Autotech solutions innovator, today announced first quarter results for the period ended March 31, 2024. Q1 revenue was up 29 percent year-over-year to $52.4 million with Non-GAAP gross margin of 50.3 percent. On a GAAP basis, first quarter 2024 operating loss was $49.6 million compared to $37.0 million a year ago. Non-GAAP operating loss for”
SOUNDHOUND AI, INC. reported first quarter 2024 results: revenue $11.6 million, net income $33.0 million, EPS $0.12. Guidance raised.
“(PRESS RELEASE, DATED MAY 9, 2024) --- EX-99.1 2 ea020567501ex99-1_sound.htm PRESS RELEASE, DATED MAY 9, 2024 Exhibit 99.1 SoundHound AI Reports 73% Q1 Revenue Growth to $11.6 Million; First Quarter Closes With $226 Million in Cash Company Raises Full Year Revenue Outlook SANTA CLARA, Calif.--( BUSINESS WIRE )--SoundHound AI, Inc. (Nasdaq: SOUN), a global”
Janus International Group, Inc. reported the quarter ended March 30, 2024 results: revenue $254.5 million, net income $30.7 million, EPS $0.21 per diluted share. Guidance reaffirmed.
“and other commercial and industrial sectors, today announced financial results for the first quarter ended March 30, 2024. First Quarter 2024 Highlights • Revenues of $254.5 million, a 1.0% increase compared to $251.9 million for the first quarter of 2023, as total Self-Storage revenues were up 11.0% which was offset somewhat by declines in Commercial and”
Rigetti Computing, Inc. reported the three months ended March 31, 2024 results: revenue $3.1 million, net income $20.8 million.
“its financial results for the first quarter ended March 31, 2024. First Quarter 2024 Financial Highlights ● Total revenues for the three months ended March 31, 2024 were $3.1 million ● Total operating expenses for the three months ended March 31, 2024 were $18.1 million ● Operating loss for the three months ended March 31, 2024 was $16.6 million ● Net loss”
Getaround, Inc reported first quarter of 2024 ended March 31, 2024 results: revenue $17.2 million, net income $31.0 million.
“Total Revenues of $17.2 million, an increase of 49% year-over-year”
SmartRent, Inc. reported three months ended March 31, 2024 results: revenue $50.5 million, net income $(7.7) million. Guidance reaffirmed.
“is hosting an investor call to discuss results today, May 8, 2024, at 11:30 a.m. Eastern Time. Financial and Business Highlights for the First Quarter 2024 • Total Revenue of $50.5 million, decreased by 22 percent year-over year. • SaaS Revenue of $11.9 million, increased by 32 percent year-over year. • Net Loss of $(7.7) million, improved by 42 percent from”
Coya Therapeutics, Inc. reported the quarter ended March 31, 2024 results: net income Net loss was $5.1 million for the three months ended March 31, 2024.
“Net loss was $5.1 million for the three months ended March 31, 2024, compared to net loss of $2.7 million for the three months ended March 31, 2023.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.